Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-03-01 @ 9:45 AM
Study NCT ID:
NCT04089267
Status:
COMPLETED
Last Update Posted:
2019-09-13
First Post:
2019-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)
Sponsor:
Shenyang Sunshine Pharmaceutical Co., LTD.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3sbio-TPO-403
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None